U.S. to procure additional 100 million doses of J&J COVID-19 vaccine: official

FILE PHOTO: A vial of the Johnson & Johnson’s coronavirus disease (COVID-19) vaccine is seen at Northwell Health’s South Shore University Hospital in Bay Shore, New York, U.S., March 3, 2021. REUTERS/Shannon Stapleton

WASHINGTON (Reuters) – The United States plans to double its order of the single-shot Johnson & Johnson coronavirus vaccine, procuring an additional 100 million doses, a White House official said on Wednesday.

President Joe Biden will make the announcement at a meeting with the chief executives of J&J and Merck & Co later in the day, the official said. Merck has agreed to partner with J&J to produce its vaccine.

J&J’s manufacturing has been slower than expected, and the company was not expected to be able to deliver any doses of its vaccine this week. It is expected to resume shipments later in March.

Source: Read Full Article

Related posts:
  1. South Africa puts AstraZeneca vaccinations on hold over variant data
  2. Fauci says U.S. political divisions contributed to 500,000 dead from COVID-19
  3. Indonesia permits private COVID-19 vaccination scheme
  4. Hungary announces lockdown as COVID-19 cases spike: PM's chief of staff
  5. Japan's Takeda seeks govt approval for Moderna COVID-19 vaccine